Zobrazeno 1 - 2
of 2
pro vyhledávání: '"629"'
Autor:
De-Yu Lin, Shih-Ping Lin, Mao-Song Tsai, Yi-Chien Lee, Hung-Jen Tang, Shu-Hsing Cheng, Chia-Jui Yang, Chun-Eng Liu, Chien-Yu Cheng, Hsin-Yun Sun, Ning-Chi Wang, Pei-Ying Wu, Yi-Chieh Lee, Chien-Ching Hung
Publikováno v:
PLoS ONE, Vol 12, Iss 2, p e0171596 (2017)
PLoS ONE
PLoS ONE
Objectives Two nucleos(t)ide reverse-transcriptase inhibitors (NRTIs) plus 1 non-NRTI (nNRTI) remain the preferred or alternative combination antiretroviral therapy (cART) for antiretroviral-naive HIV-positive patients in Taiwan. The three most commo
Autor:
Tatsuya Ide, Yuichiro Eguchi, Masaru Harada, Kunihide Ishii, Masaru Morita, Yasuyo Morita, Gen Sugiyama, Hirofumi Fukushima, Yoichi Yano, Kazunori Noguchi, Hiroki Nakamura, Junjiro Hisatomi, Hiroto Kumemura, Miki Shirachi, Shinji Iwane, Michiaki Okada, Yuichi Honma, Teruko Arinaga-Hino, Ichiro Miyajima, Kei Ogata, Reiichiro Kuwahara, Keisuke Amano, Toshihiro Kawaguchi, Ryoko Kuromatsu, Takuji Torimura, DAAs Multicenter Study Group
Publikováno v:
PLoS ONE, Vol 11, Iss 9, p e0163884 (2016)
PLoS ONE
PLoS ONE
Background The aim of this study was to evaluate the efficacy of daclatasvir plus asunaprevir therapy in patients infected with hepatitis C virus and determine its relevance to resistant variants. Methods A total of 629 consecutive patients infected